Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Transcription factors control invasion: AP-1 the first among equals

Oncogene volume 26, pages 1–10 (2007)Cite this article

Abstract

Metastasis, the aggressive spread of a malignant tumor to distant organs, is a major cause of death in cancer patients. Despite this critical role in cancer outcomes, the molecular mechanisms that control this process are just beginning to be understood. Metastasis is largely dependent upon the ability of tumor cells to invade the barrier formed by the basement membrane and to migrate through neighboring tissues. This review will summarize the evidence that tumor cell invasion is the result of oncogene-mediated signal transduction pathways that control the expression of a specific set of genes that together mediate tumor cell invasion. We focus on the role of the transcription factor AP-1 to both induce the expression of genes that function as invasion effectors and repress other genes that function as invasion suppressors. This identifies AP-1 as a critical regulator of a complex program of gene expression that defines the invasive phenotype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Alani R, Brown P, Binetruy B, Dosaka H, Rosenberg RK, Angel P et al. (1991). Mol Cell Biol 11: 6286.

  • Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD et al. (2003). Clin Orthop Relat Res 415 (Suppl): S75–S85.

  • Andersen H, Mejlvang J, Mahmood S, Gromova I, Gromov P, Lukanidin E et al. (2005). Mol Cell Biol 25: 9138–9150.

  • Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rhamsdorf HJ et al. (1987). Cell 49: 729.

  • Bahassi el M, Karyala S, Tomlinson CR, Sartor MA, Medvedovic M, Hennigan RF . (2004). Clin Exp Metast 21: 293–304.

  • Bailly M, Condeelis JS, Segall JE . (1998). Microsc Res Tech 43: 433–443.

  • Bakin AV, Curran T . (1999). Science 283: 387–390.

  • Bassunk AG, Leiden JM . (1995). Immunity 3: 223.

  • Belguise K, Kersual N, Galtier F, Chalbos D . (2005). Oncogene 24: 1434–1444.

  • Benbow U, Brinckerhoff CE . (1997). Matrix Biol 15: 519.

  • Bernards R, Weinberg RA . (2002). Nature 418: 823.

  • Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA . (2004). Oncogene 23: 2357–2366.

  • Blatti SP, Foster DN, Rangnathan G, Moses HL, Getz MJ . (1988). Proc Natl Acad Sci 85: 1119.

  • Bos TJ, Bohmann D, Tsuchie H, Tjian R, Vogt PK . (1988). Cell 52: 705–712.

  • Bos TJ, Margiotta P, Bush L, Wasilenko W . (1999). Int J Cancer 81: 404.

  • Bos TJ, Monteclaro FS, Mitsunobu F, Ball Jr AR, Chang CH, Nishimura T et al. (1990). Genes Dev 4: 1677–1687.

  • Bradley MO, Kraynak AR, Storer RD, Gibbs JB . (1986). Proc Natl Acad Sci USA 83: 5277–5281.

  • Briggs J, Chamboredon S, Castellazzi M, Kerry JA, Bos TJ . (2002). Oncogene 21: 7077–7091.

  • Brown R, Marshall CJ, Pennie SG, Hall A . (1984). EMBO J 3: 1321.

  • Campbell PM, Der CJ . (2004). Semin Cancer Biol 14: 105–114.

  • Chen RH, Juo PC, Curran T, Blenis J . (1996). Oncogene 12: 1493–1502.

  • Chen WL, Narayanan R, Hibbs MS, Benn PA, Clawson ML, Lu G et al. (1993). Biochem Biophys Res Commun 193: 167.

  • Cohen SB, Waha A, Gelman IH, Vogt PK . (2001). Oncogene 20: 141–146.

  • Curran T, Franza Jr BR . (1988). Cell 55: 395–397.

  • Curran T, Teich NM . (1982). J Virol 42: 114.

  • Curran T, Verma IM . (1984). Virology 135: 218–228.

  • Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA . (1987). Oncogene 2: 55.

  • Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR . (1990). Science 249: 1266.

  • Dong Z, Crawford HC, Lavrovsky V, Taub D, Watts R, Matrisian LM et al. (1997). Mol Carcinog 19: 204–212.

  • Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, Revazova E et al. (1989). Genes Dev 3: 1086–1093.

  • Eferl R, Wagner EF . (2003). Nat Rev Cancer 3: 859–868.

  • Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M et al. (2003). Cell 112: 181–192.

  • Fearon ER, Vogelstein B . (1990). Cell 61: 759.

  • Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, Beug H . (1996). J Cell Biol 132: 1115.

  • Fidler IJ . (2002). Semin Cancer Biol 12: 89–96.

  • Foos G, Hauser CA . (2000). Oncogene 19: 5507–5516.

  • Gaub MP, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P . (1990). Cell 63: 1267.

  • Grinnell F . (1994). J Cell Biol 124: 401.

  • Hanahan D, Weinberg RA . (2000). Cell 100: 57–70.

  • Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K et al. (2000). Carcinogenesis 21: 1079–1085.

  • Hawker KL, Pintzas A, Hennigan RF, Gillespie DA, Ozanne BW . (1993). J Virol 67: 5487–5495.

  • Helbig G, Christopherson II KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). J Biol Chem 278: 21631–21638.

  • Hennigan RF, Hawker KL, Ozanne BW . (1994). Oncogene 9: 3591–3600.

  • Hernandez-Alcoceba R, del Peso L, Lacal JC . (2000). Cell Mol Life Sci 57: 65–76.

  • Johnson R, Spiegelman B, Hanahan D, Wisdom R . (1996). Mol Cell Biol 16: 4504–4511.

  • Johnston IM, Spence HJ, Winnie JN, McGarry L, Vass JK, Meagher L et al. (2000). Oncogene 19: 5348–5358.

  • Joos KU, Muller R . (1995). Oncogene 10: 603.

  • Kovary K, Rizzo CA, Ryseck RP, Noguchi T, Raynoschek C, Pelosin JM et al. (1991). New Biol 3: 870.

  • Kralova J, Liss AS, Bargmann W, Bose Jr HR . (1998). Mol Cell Biol 18: 2997–3009.

  • Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP et al. (2001). Nat Genet 27: 427–430.

  • Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E et al. (1998). Mol Cell Biol 18: 7095–7105.

  • Ky M, Yoshida K, Higashino F, Mitka T, Ishii S, Fuginga K . (1996). Oncogene 12: 221.

  • Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD et al. (1997a). Mol Cell Biol 17: 963–976.

  • Lamb RF, Ozanne BW, Roy C, McGarry L, Stipp C, Mangeat P et al. (1997b). Curr Biol 7: 682–688.

  • Lanahan A, Williams JB, Sanders LK, Nathans D . (1992). Mol Cell Biol 12: 3919.

  • Ledwith BJ, Manam S, Kraynak AR, Nichols WW, Bradley MO . (1990). Mol Cell Biol 10: 1545.

  • Lee MS, Yang JH, Salehi Z, Arnstein P, Chen LS, Jay G et al. (1993). Oncogene 8: 387.

  • Lee W, Mitchell P, Tjian R . (1987). Cell 49: 741–752.

  • Li JJ, Rhin JS, Schlegel R, Vousden K, Colburn NH . (1998). Oncogene 16: 2711.

  • Lindholm PF, Bub J, Kaul S, Shidham VB, Kajdacsy-Balla A . (2000). Clin Exp Metast 18: 471–479.

  • Liotta LA, Steeg PS, Stetler-Stevenson WG . (1991). Cell 64: 327.

  • Liu S, Wang L, Wang W, Lin J, Han J, Sun H et al. (2006). Exp Mol Pathol 80: 132–140.

  • Lloyd A, Yancheva N, Wasylyk B . (1991). Nature 352: 635–638.

  • Ma Z, Shah RC, Chang MJ, Benveniste EN . (2004). Mol Cell Biol 24: 5496–5509.

  • Malliri A, Symons M, Hennigan RF, Hurlstone AF, Lamb RF, Wheeler T et al. (1998). J Cell Biol 143: 1087–1099.

  • Mashimo J, Maniwa R, Sugino H, Nose K . (1997). Cancer Lett 113: 213–219.

  • McGarry LC, Winnie JN, Ozanne BW . (2004). Oncogene 23: 5284–5292.

  • Melchiori A, Carlone S, Allavena G, Aresu O, Parodi S, Aaronson SA et al. (1990). Anticancer Res 10: 37.

  • Mercola D, Rundell A, Westwick J, Edwards SA . (1987). Biochem Biophys Res Commun 147: 288.

  • Merlino GT, Xu YH, Ishii S, Clark AJ, Semba K, Toyoshima K et al. (1984). Science 224: 417–419.

  • Miao GG, Curran T . (1994). Mol Cell Biol 14: 4295–4310.

  • Milde-Langosch K . (2005). Eur J Cancer 41: 2449–2461.

  • Miller AD, Curran T, Verma IM . (1984). Cell 36: 51–60.

  • Muller R, Bravo R, Burckhardt J, Curran T . (1984). Nature 312: 716–720.

  • Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B et al. (2005). Int J Oncol 27: 949–956.

  • Nolan GP . (1994). Cell 77: 795–798.

  • Okuno H, Suzuki T, Yoshida T, Hashimoto Y, Curran T, Iba H . (1991). Oncogene 6: 1491–1497.

  • Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C . (1997). J Biol Chem 272: 18586–18594.

  • Ordway JM, Curran T . (2002). Cell Growth Differ 13: 149–162.

  • Ordway JM, Williams K, Curran T . (2004). Oncogene 23: 3737–3748.

  • Ozanne BW, McGarry L, Spence HJ, Johnston I, Winnie J, Meagher L et al. (2000). Eur J Cancer 36: 1640–1648.

  • Partin AW, Isaacs JT, Treiger B, Coffey DS . (1988). Cancer Res 48: 6050–6053.

  • Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H et al. (1998). Mol Endocrinol 12: 973–985.

  • Price CH, Moore M, Jones DB . (1972). Br J Cancer 26: 15–27.

  • Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR . (1991). Nature 353: 670.

  • Raz A, Pazerini G, Carmi P . (1989). Cancer Res 49: 3489.

  • Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J et al. (1992). Cell 71: 1103.

  • Ridley AJ, Hall A . (1992). Cell 70: 389.

  • Rinehart-Kim J, Johnston M, Birrer M, Bos T . (2000). Int J Cancer 88: 180–190.

  • Rivat C, Le Floch N, Sabbah M, Teyrol I, Redeuilh G, Bruyneel E et al. (2003). Faseb J 17: 1721–1723.

  • Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH et al. (1995). Cell 82: 721.

  • Sapi E, Flick MB, Rodov S, Kacinski BM . (1998). Cancer Res 58: 1027–1033.

  • Schuh AC, Keating SJ, Monteclaro FS, Vogt PK, Breitman ML . (1990). Nature 346: 756.

  • Scott LA, Vass JK, Parkinson EK, Gillespie DA, Winnie JN, Ozanne BW . (2004). Mol Cell Biol 24: 1540–1559.

  • Seth A, Catzavelos C, Vary C, Ascione R . (2001). Expert Opin Ther Targets 5: 87–107.

  • Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M . (1991). Nature 354: 494.

  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). J Clin Invest 100: 2952–2960.

  • Spence HJ, Johnston I, Ewart K, Buchanan SJ, Fitzgerald U, Ozanne BW . (2000). Oncogene 19: 1266–1276.

  • Spence HJ, McGarry L, Chew CS, Carragher NO, Scott-Carragher LA, Yuan Z et al. (2006). Mol Cell Biol 26: 1480–1495.

  • Stapleton G, Malliri A, Ozanne BW . (2002). J Cell Sci 115: 2713–2724.

  • Stein B, Baldwin Jr AS, Ballard DW, Greene WC, Angel P, Herrlich P . (1993). EMBO J 12: 3879–3891.

  • Stolz DB, Michalopoulos GK . (1994). J Cell Biochem 55: 445–464.

  • Sun HQ, Kwiatkowska K, Wooten DC, Yin HL . (1995). J Cell Biol 129: 147.

  • Taniguchi S, Tatsuka M, Nakamatsu K, Ionue M, Sadano H, Okazaki H et al. (1989). Cancer Res 49: 6738.

  • Tkach V, Tulchinsky E, Lukanidin E, Vinson C, Bock E, Berezin V . (2003). Oncogene 22: 5045–5054.

  • van ‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Nature 415: 530–536.

  • Verma IM, Sassone-Corsi P . (1987). Cell 51: 513.

  • Vial E, Sahai E, Marshall CJ . (2003). Cancer Cell 4: 67–79.

  • Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE . (1995). Cancer Res 55: 6244–6251.

  • Weissman I . (2005). Jama 294: 1359–1366.

  • Wisdom R . (1999). Exp Cell Res 253: 180–185.

  • Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER et al. (2004). Cancer Res 64: 7022–7029.

  • Yamaguchi H, Wyckoff J, Condeelis J . (2005). Curr Opin Cell Biol 17: 559–564.

  • Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A et al. (2001). Cancer Res 61: 5168–5178.

  • Zhang Y, Feng XH, Derynck R . (1998). Nature 394: 909.

  • Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A . (2000). Oncogene 19: 4011.

Download references

Author information

Authors and Affiliations

  1. Invasion and Metastasis Laboratory, Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Scotland, G61 1BD, Glasgow, UK

    B W Ozanne, H J Spence & L C McGarry

  2. Department of Cell Biology, University of Cincinnati, Cincinnati, OH, USA

    R F Hennigan

Authors
  1. B W Ozanne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H J Spence
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L C McGarry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R F Hennigan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R F Hennigan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozanne, B., Spence, H., McGarry, L. et al. Transcription factors control invasion: AP-1 the first among equals. Oncogene 26, 1–10 (2007). https://doi.org/10.1038/sj.onc.1209759

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209759

Keywords

This article is cited by

Search

Advanced search

Quick links